Vitamin D Overdose Risk: What Anses Actually Found About Stacking Supplements and Hypercalcemia
Anses has long warned that combining prescribed vitamin D with drops, ampoules or multivitamins can push intake into hypercalcemia range, especially in infants. Here is what the agency's data shows, and where it stops at the evidence it has.
What the claims rest on
| Product or subject | Claim | Evidence | Checked |
|---|---|---|---|
| Hypercalcemia from vitamin D toxicity | Hypercalcemia from vitamin D toxicity starts with symptoms like loss of appetite, nausea, vomiting, thirst, constipation, and frequent urination, and can lead to nephrocalcinosis with permanent kidney damage if untreated. | Clinical description of symptoms and kidney effects. |
Anses first warned about vitamin D overdose on 27 January 2021, after doctors reported severe hypercalcemia in infants. The cause traced back to adult-formulated drops, some delivering up to 10,000 IU per drop, given to babies who need around 400 IU a day. The agency repeated the warning in 2022 after three more cases of infant overdose surfaced, a pattern logged in the pharmacovigilance bulletin Vigil'Anses.
The risk Anses describes centers on stacking, not any single product. A child, or an adult on osteoporosis therapy, can end up on a prescribed cholecalciferol dose, an over-the-counter drop or ampoule, and a multivitamin that also lists vitamin D. Each source looks small on its own label. Add them together and the daily total can land far past the advised range, and nobody tracks the sum because no single doctor or pharmacist sees every product in the cabinet.
Anses recommends favoring prescription medicines over supplements for this reason: drug packaging states an exact IU dose per unit, while supplement drops vary in concentration and are easier to measure wrong, as the Ordre des pharmaciens has also advised pharmacists to explain to patients.
Hypercalcemia from vitamin D toxicity starts with symptoms easy to write off as something else: loss of appetite, nausea, vomiting, thirst, constipation, frequent urination. Left unchecked, the excess calcium can deposit in the kidneys as nephrocalcinosis, and that kidney damage can become permanent, according to MSD Manuals. Treatment means stopping every vitamin D source at once, rehydrating, sometimes through an IV line, and checking blood calcium and kidney function right away.
One documented case shows what that looks like in an adult: a man was hospitalized with hypercalcemia and impaired kidney function after dosing himself with vitamin D supplements on his own, and doctors treated him with rehydration and bisphosphonates, drugs normally used for bone disease, according to a case reported by Futura-Sciences.
The evidence base behind these warnings has a specific shape worth naming. Most of the confirmed, sourced cases concern infants and, in a separate 2024 Anses opinion, pregnant women and neonates. That same opinion found that vitamin D doses in supplements alone don't fully explain some neonatal hypercalcemia cases, and pointed instead to a genetic hypersensitivity to vitamin D as a likelier mechanism in at least some of them, according to Anses. That nuance matters for anyone reading a headline about cumulative treatment risk: the dose is one factor, and individual sensitivity is another.
Healthy adults tolerate a wider range than infants do. Clinical data cited in the same literature put the no-toxicity threshold at up to 10,000 IU a day for sixteen weeks in healthy adults, a level several times the infant danger zone. That gap is the practical takeaway: an adult combining a prescribed dose with an occasional supplement isn't automatically in the same risk category as an infant given adult-strength drops. The question to settle before adding anything new isn't whether vitamin D is good for bones. It's whether a drug, a drop, an ampoule, or a multivitamin already on the shelf already answers that need, and a pharmacist or doctor can add up the total before another bottle joins the cabinet.
